Study of Epratuzumab in Systemic Lupus Erythematosus

Clinical trial NCT00383513 · COMPLETED

Trial details

NCT number: NCT00383513
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2006-06-01
Primary completion: 2012-01-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.